首页> 外文期刊>Arquivos de Gastroenterologia >Evaluation of small intestine bacterial overgrowth in patients with functional dyspepsia through H2 breath test
【24h】

Evaluation of small intestine bacterial overgrowth in patients with functional dyspepsia through H2 breath test

机译:通过H2呼气试验评估功能性消化不良患者小肠细菌过度生长

获取原文
           

摘要

CONTEXT: Functional dyspepsia is a condition in which symptoms are not related to organic underlying disease; its pathogenesis is not well known. The small intestinal bacterial overgrowth (SIBO) is characterized by the increase in the number and/or type of colonic bacteria in the upper gastrointestinal tract. The hypothesis of SIBO being associated to functional dyspepsia must be considered, since the impaired motility of the gastrointestinal tract is one of the main etiologic factors involved on both pathologies. OBJECTIVE: To determine if there is SIBO in patients with functional dyspepsia. METHODS: Case-control study, evaluating 34 patients: 23 functional dyspeptic and 11 non-dyspeptic (control group). Questionnaire applied based on Rome III criteria. The patients underwent H2-lactulose breath test, considered positive when: H2 peak exceeding 20 ppm, in relation to fasting, or two peaks exceeding 10 ppm sustained until 60 minutes. RESULTS: Of the 23 dyspeptic patients, 13 (56.5%) obtained positive results for SIBO trough the H2-lactulose breath test. On control group, SIBO was not observed. The association between the dyspeptic group and the control group regarding SIBO was statistically significant, with P = 0.0052. In the group of dyspeptic patients, 12 (52.2%) were using proton pump inhibitor; of these 9 (75%) were positive for SIBO. In the control group, none of the 11 patients used proton pump inhibitors and SIBO was not observed. The association of the dyspeptic group using proton pump inhibitor that were positive for SIBO and the control group was statistically significant, with P = 0.0011. CONCLUSION: It was found that, patients with functional dyspepsia presented SIBO, when they underwent to H2-lactulose breath test, compared to the non-dyspeptic. In addition, it was observed a higher prevalence of SIBO in dyspeptic patients that were using proton pump inhibitors, compared to control group.
机译:背景:功能性消化不良是指症状与器质性基础疾病无关的疾病。其发病机制尚不清楚。小肠细菌过度生长(SIBO)的特征是上消化道中结肠细菌的数量和/或类型增加。必须考虑SIBO与功能性消化不良有关的假说,因为胃肠道运动能力受损是这两种病理学的主要病因之一。目的:确定功能性消化不良患者是否存在SIBO。方法:病例对照研究,评估34例患者:23例功能性消化不良和11例非消化不良(对照组)。根据罗马三世标准应用问卷。患者接受了H2-乳果糖呼气试验,在以下情况下被认为是阳性的:H2峰值超过20 ppm(相对于禁食),或两个峰值超过10 ppm的持续60分钟。结果:在23名消化不良患者中,有13名(56.5%)通过H2-乳果糖呼气试验获得了SIBO阳性结果。对照组未观察到SIBO。消化不良组与对照组之间关于SIBO的相关性具有统计学意义,P = 0.0052。在消化不良患者组中,有12名(52.2%)使用质子泵抑制剂。这9个(75%)中的SIBO阳性。在对照组中,这11例患者均未使用质子泵抑制剂,未观察到SIBO。消化不良组使用质子泵抑制剂对SIBO呈阳性,而对照组则具有统计学意义,P = 0.0011。结论:与非消化不良患者相比,功能性消化不良患者接受H2-乳果糖呼气试验时出现SIBO。此外,与对照组相比,在使用质子泵抑制剂的消化不良患者中,SIBO的患病率更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号